Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
6311638
Reference Type
Journal Article
Title
Bipolar Hemiarthroplasty should not be selected as the primary option for intertrochanteric fractures in elderly patients
Author(s)
Huang, J; Shi, Y; Pan, W; Wang, Z; Dong, Y; Bai, Y; Wang, A; Zhao, Y; Zheng, J; Lian, H
Year
2020
Is Peer Reviewed?
1
Journal
Scientific Reports
EISSN:
2045-2322
Volume
10
Issue
1
Page Numbers
4840
Language
English
PMID
32179789
DOI
10.1038/s41598-020-61387-3
Web of Science Id
WOS:000546797900001
Abstract
Intertrochanteric fractures (ITFs) in the elderly are still a big challenge for clinical doctors. Although proximal femoral nail antirotation (PFNA) and bipolar hemiarthroplasty (BPH) are selected by most of the orthopaedic surgeons for elderly ITFs patients, there is still no consensus on the superiority of PFNA and BPH for ITFs in elderly. In this study, we hypothesized that BPH should not be selected as the primary option for ITFs in elderly patients, and analyzed clinical data of 202 elderly ITFs patients aged 80 years or more treated with PFNA (Group A) and BPH (Group B) to compare the early outcome of PFNA and BPH for ITFs in elderly patients aged 80 years or more. We found that operation time and blood loss during surgery in group A are less than in Group B. Time of weight bearing after operation in Group A is longer than in Group B. Incidence of complications 2 weeks after operation in Group A is 9.29% less than 25.81% in Group B (χ2 = 9.539, p = 0.002). Mortality rates 12 months after operation in Group A is 11.43% similar with 19.35% in Group B (χ2 = 2.261, p = 0.133). Harris Hip Score 12 months after operation in Group A is 68.00 ± 29.11 points similar with 65.73 ± 33.29 points in Group B (t = 0.490, p = 0.625). Therefore, for elderly ITFs patients aged 80 years or more, BPH should not be selected as the primary option for ITFs in elderly patients.
Tags
PFAS
•
Additional PFAS (formerly XAgency)
•
PFAS 150
Missing 2021 searches
Not prioritized for screening
•
PFNA
Literature Search
Pubmed
WOS
LitSearch: May 2019 - May 2020
PubMed
LitSearch: May 2020 - April 2021
WoS
Title and Abstract Screening
Excluded
Not relevant to PECO
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity